Loading patent…
AssigneeJuridical Foundation The Chemo-Sero-Therapeutic Research Institute
InventorsTatsuya Araki, Kazuhiko Tomokiyo, Yasushi Nakatomi, Kaori Teshima, Tomoko Watanabe, Tomohiro Nakagaki
Estimating the term…
The present invention provides a pharmaceutical composition for treatment and prevention of bleeding disorders caused by platelet disorders, not caused by defect in blood coagulation factors or von Willebrand Factor but caused by reduction of circulating platelet count or platelet dysfunction, said composition comprising a hemostatic effective amount of Factor VIII and/or von Willebrand Factor. Also provided is a method for treating said bleeding, comprising administering a hemostatic effective amount of Factor VIII and/or von Willebrand Factor to patients suffering from bleeding disorders caused by platelet disorders.
A pharmaceutical composition for treatment and prevention of bleeding disorders caused by platelet disorders, comprising a hemostatic effective amount of Factor VIII as an active ingredient.
A method for treating bleeding disorders caused by platelet disorders, comprising administering a hemostatic effective amount of Factor VIII to patients suffering from bleeding disorders caused by platelet disorders.
A pharmaceutical composition for treatment and prevention of bleeding disorders caused by platelet disorders, comprising a hemostatic effective amount of von Willebrand Factor as an active ingredient.
A method for treating bleeding disorders caused by platelet disorders, comprising administering a hemostatic effective amount of von Willebrand Factor to patients suffering from bleeding disorders caused by platelet disorders.
Dependencies are inferred from the claim text.